Covid-19: Leading expert assures Geneva ‘under control’
Despite the immediate closure of all nightclubs following a spike in coronavirus cases linked to the establishments, Didier Pittet, head of infection prevention at Geneva’s University Hospital, said the situation was under control.
This content was published on
3 minutes
Paula Dupraz-Dobias in Geneva
While Geneva recorded a sharp riseExternal link in cases during the last week of July, Pittet, one of the country’s leading specialists in infectious diseases said the canton was among those “where screening is most active”.
Pittet was speaking on Monday at an online news conference with the Association of Accredited Correspondents at the United Nations (ACANU) in Geneva.
“It is not considered to be a hotspot,” he added. “It is certainly under control.”
Geneva, which has been to date the second hardest hit canton in total number of cases of Covid-19 after neighbouring Vaud, reportedExternal link 235 confirmed active cases during the week ending 30 July, an increase from 87 confirmed cases the previous week.
Zurich, the canton with the second highest number of active cases, recorded 150 cases the last week of July, when Switzerland had a total of 820 active cases.
Pittet said that 40% of cases in Geneva were linked to discotheques and bars, 25%-30% to transmission within families and approximately a quarter to infection that had originated outside of Switzerland. Nearly half of newly confirmed cases are among young people and adults.
“When you have good epidemiological evidence, you can know where cases are coming from,” he said.
Holidays abroad
Following the closure of the nightclubs, Pittet expected such data to shift as people return from holidays abroad.
“Autumn will not be easy,” the professor said, given an expected rise in other respiratory syndromes, including the seasonal flu. Certain social and economic activities, for instance religious gatherings or work done in small, closed quarters, may have to suspended to avoid a return to tighter confinement conditions, he said.
But while some international public health experts, drug executives and politicians have expressed the possibility of having a vaccine against the virus in the final months of 2020, Pittet was much more cautious.
“There is no chance to have a vaccine before the end of the year. Maybe, if we are lucky there may be a vaccine available by spring,” Pittet said.
Last week, Russia announced it would start a mass coronavirus vaccine campaign in October, while the authorities in the United States and pharmaceutical executives predicted vaccines may come that month.External link
Vaccine
Anthony Fauci, the director of the US National Institute of Allergy and Infectious Diseases, recently said that he was “cautiously optimistic” that a clinical trial underway will lead to an effective vaccine.
Christian Baumann of the University of Bern for his part spoke of vaccinating the Swiss population in October.
And for Swiss Interior Minister Alain Berset one thing is certain.
“The Swiss population should have the fastest possible access to a safe, effective vaccine. But we also know there’s a big, global discussion going on, and need will be huge worldwide. All countries should have fair access to a vaccine.”
“Until everyone may benefit from the vaccine, it will take another 18 months or even two years,” Pittet cautioned. “It is unfair to say but there will be places that will be covered quicker than others.”
More
More
Swiss focus on vaccine and diagnostics in global fight against Covid-19
This content was published on
The government has approved CHF175 million in funds to help secure universal access to diagnostic and therapeutic products and boost humanitarian aid.
This content was published on
Switzerland remains by a large margin the European champion of train travel, both in terms of the number of journeys per person and the number of kilometres travelled. Switzerland remains by a large margin the European champion of train travel, both in terms of the number of journeys per person and the number of kilometres travelled. Switzerland remains by a large margin the European champion of train travel, both in terms of the number of journeys per person and the number of kilometres travelled.
Swiss price watchdog slams excessive prices for generic medicines
This content was published on
The cheapest generic medicines available in Switzerland are more than twice as expensive as in other countries, according to a study by the Swiss price watchdog.
Nature should not figure in net zero calculations: academic study
This content was published on
The natural removal of CO2 from the atmosphere by forests or oceans should not be included in the net-zero balance of climate protection measures, argue researchers.
This content was published on
None of the 15 major Swiss retail banks is meeting international climate and biodiversity targets, according to a ranking by WWF Switzerland.
This content was published on
Nestlé's new CEO Laurent Freixe, has presented plans for the future of the world's largest food company, after his first few weeks in office.
Swiss foreign minister calls on Moscow to end Ukraine war
This content was published on
It's high time Moscow ended its war against Ukraine, Swiss foreign minister Ignazio Cassis tells the UN Security Council.
This content was published on
The only alternative to the UN Palestinian agency’s work in Gaza is to allow Israel to run services there, Philippe Lazzarini, UNRWA Commissioner-General, told reporters in Geneva on Monday.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Coronavirus vaccine study reportedly stalled for lack of cash
This content was published on
Six Swiss hospitals are ready for a first big Covid-19 vaccine study but it can’t start for lack of money, writes a Sunday newspaper.
Lausanne hospital test chosen for coronavirus study
This content was published on
A test developed at Lausanne university hospital has been chosen for wide-scale coronavirus antibody studies of the Swiss population.
Covid-19 therapy could come by end of year, vaccine in 2021
This content was published on
Swiss pharma and business insiders predict that an effective drug therapy against Covid-19 will be available by the end of this year, but a vaccine might take a year longer than that.
This content was published on
It’s the question we all want an answer to: when will there be a vaccine against Covid-19? And how is fair access being negotiated?
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.